Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
From the initial assessment to creating your personalized plan, we're here to support you every step of the way
Verdict at a Glance Tirzepatide is the proven choice with robust phase 3 data showing up to 20.9% weight loss and FDA approval for both diabetes and obesity
Thanks This product has given me more energy and I feel like my belly fat has decreased
Six pen strengths are available
Retatrutide is not approved anywhere, Eli Lilly had not filed an NDA as of mid-2026, and its long-term safety data is still maturing
US$ 29.78
US$ 23.90
US$ 22.25
US$ 26.46
